발현 벡터 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 호스트 유형별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)
Expression Vector Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Host Type, By Application, By End User, By Region and Competition, 2020-2030F
상품코드:1691805
리서치사:TechSci Research
발행일:2025년 03월
페이지 정보:영문 182 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계 발현 벡터 시장은 2024년 4억 4,050만 달러로 평가되며, 2030년까지 연평균 5.10%의 CAGR로 예측 기간 동안 괄목할 만한 성장을 이룰 것으로 예상됩니다.
발현 벡터는 생명공학 및 분자생물학에서 숙주 세포 내에서 특정 유전자를 운반하고 발현시키기 위해 사용되는 DNA 분자의 일종입니다. 발현 벡터는 그것이 운반하는 유전자로부터 단백질 또는 다른 유전자 산물의 생산을 용이하게 하도록 설계되어 있습니다. 외래 유전물질(예: 원하는 유전자)을 숙주 세포에 도입하기 위한 분자적 매개체 역할을 하며, 여기서 유전자가 전사되고 번역되어 기능성 단백질을 생산할 수 있습니다. 발현 벡터는 유전자의 전사를 시작하는 스위치 역할을 하는 특정 DNA 서열인 프로모터 영역을 포함하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
4억 4,050만 달러
시장 규모 : 2030년
5억 8,884만 달러
CAGR : 2025-2030년
5.10%
급성장 부문
치료제
최대 시장
북미
프로모터는 그 강도와 특이성에 따라 선택되는 경우가 많으며, 목적하는 유전자 발현 수준과 숙주 세포의 종류에 따라 달라집니다. 발현 벡터에는 복제 기점이 있는데, 이는 숙주 세포의 복제 장치에 의해 인식되는 DNA 염기서열입니다. 이 염기서열에 의해 벡터는 숙주세포 내에서 복제 및 증식하고, 도입된 유전자가 세포분열 중에 딸세포로 확실하게 전달됩니다.
Global Expression Vector Market was valued at USD 440.50 million in 2024 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 5.10% through 2030. An expression vector is a type of DNA molecule used in biotechnology and molecular biology to carry and express specific genes within host cells. Expression vectors are designed to facilitate the production of proteins or other gene products from the genes they carry. They serve as molecular vehicles for introducing foreign genetic material (e.g., a gene of interest) into host cells, where the gene can be transcribed and translated to produce a functional protein. Expression vectors contain a promoter region, which is a specific DNA sequence that acts as a switch to initiate gene transcription.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 440.50 Million
Market Size 2030
USD 588.84 Million
CAGR 2025-2030
5.10%
Fastest Growing Segment
Therapeutics
Largest Market
North America
Promoters are often chosen based on their strength and specificity, depending on the desired level of gene expression and the type of host cell. Expression vectors have an origin of replication, which is a DNA sequence recognized by the host cell's replication machinery. This sequence allows the vector to replicate and propagate inside the host cell, ensuring that the introduced gene is passed on to daughter cells during cell division.
Key Market Drivers
Gene Therapy Expansion
Expression vectors serve as crucial gene delivery vehicles in gene therapy. They are used to transport therapeutic genes into target cells, facilitating the correction of genetic defects or the introduction of therapeutic genes to treat various diseases. Gene therapy has expanded beyond rare diseases to include a wide range of therapeutic applications, such as cancer treatment, genetic disorders, neurological diseases, and cardiovascular conditions. Each application may require tailored expression vectors to achieve optimal gene delivery and expression. The increasing number of gene therapy clinical trials and the approval of gene therapies by regulatory agencies drive demand for expression vectors. These vectors are essential for producing therapeutic genes used in clinical studies and commercialized treatments. Gene therapy research often demands customized expression vectors. Researchers and biotech companies may require vectors that are specific to their therapeutic targets, ensuring precise gene delivery and appropriate expression levels. Many gene therapies rely on viral vectors, such as adeno-associated virus (AAV) vectors and lentiviral vectors, for gene delivery. The development and commercialization of viral vector-based gene therapies have led to a surge in demand for these vectors. For instance, according to the World Health Organization (WHO) in 2021, non-communicable diseases (NCDs) account for 41 million deaths annually, representing 71% of all global deaths. Over 15 million people aged 30 to 69 die each year from NCDs, highlighting their significant impact on public health worldwide.
Key Market Challenges
Safety Concerns
Expression vectors, particularly those used in gene therapy and biopharmaceutical production, must adhere to strict biosafety regulations. Ensuring that vectors do not pose risks to human health, or the environment is essential. Biosafety levels and containment measures are established to prevent accidental release or exposure to genetically modified organisms (GMOs) and biohazardous materials. The use of expression vectors for gene editing, such as CRISPR-Cas9 technology, raises concerns about off-target effects and unintended genetic modifications. Ensuring the precision and safety of gene editing procedures is a critical challenge. The release of genetically modified organisms into the environment, even unintentionally, can have ecological consequences. Proper containment and disposal methods are necessary to prevent environmental contamination. In gene therapy, the integration of expression vectors into the host genome may pose long-term safety risks. Insertional mutagenesis, where vector integration disrupts normal gene function, is a concern. In biopharmaceuticals, the presence of vector-related proteins or antigens in therapeutic products can trigger an immune response in patients, leading to safety issues and reduced efficacy. Achieving tissue-specific expression using expression vectors is challenging but critical for minimizing off-target effects and ensuring safety in gene therapy applications. Viral vectors used in gene therapy can trigger immune responses in patients. Strategies to mitigate vector immunogenicity are essential to improve safety and therapeutic efficacy.
Key Market Trends
Environmental Sustainability
Biotechnology companies are increasingly adopting green bioprocessing practices that reduce the environmental impact of expression vector production. This includes optimizing fermentation processes to minimize waste, energy consumption, and resource use. There is a growing demand for expression vector systems that are environmentally friendly. Companies are developing vector systems that use fewer resources and generate less waste during production. Research and development efforts are focused on creating biodegradable vectors that break down naturally after use, reducing the environmental burden of vector disposal. Companies are exploring sustainable sourcing of raw materials used in vector production, such as growth media components, to reduce the environmental footprint of vector manufacturing. Investments in energy-efficient biomanufacturing processes and facilities are becoming more common. This reduces energy consumption during vector production and contributes to sustainability goals. Sustainable practices aim to minimize waste generation throughout the vector production process. This includes recycling and reusing materials when possible. Companies are taking steps to measure and reduce the carbon footprint associated with vector production and distribution. This may involve using renewable energy sources and optimizing transportation logistics.
Key Market Players
Thermo Fisher Scientific, Inc.,
Promega Corporation
Agilent Technologies, Inc.
Bio-Rad Laboratories Inc.
QIAGEN NV
Merck KGaA
TAKARA HOLDINGS Inc.
GenScript Corp.
Quest Diagnostics
Addgene, Inc.
Report Scope:
In this report, the Global Expression Vector Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Expression Vector Market, By Host Type:
Bacterial expression vectors
Mammalian expression vectors
Insect expression vectors
Yeast expression vector
Others
Expression Vector Market, By Application:
Therapeutic
Research
Others
Expression Vector Market, By End-User:
Pharmaceutical & biotech
Academic research
Others
Expression Vector Market, By region:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
South Korea
Australia
Japan
Europe
Germany
France
United Kingdom
Spain
Italy
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Expression Vector Market.
Available Customizations:
Global Expression Vector Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Expression Vector Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Host Type (Bacterial expression vectors, Mammalian expression vectors, Insect expression vectors, Yeast expression vector, Others)
5.2.2. By Application (Therapeutic, Research, Others)
5.2.3. By End User (Pharmaceutical & biotech, Academic research, Others),
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. Asia Pacific Expression Vector Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Host Type
6.2.2. By Application
6.2.3. By End-User
6.2.4. By Country
6.3. Asia Pacific: Country Analysis
6.3.1. China Expression Vector Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Host Type
6.3.1.2.2. By Application
6.3.1.2.3. By End-User
6.3.2. India Expression Vector Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Host Type
6.3.2.2.2. By Application
6.3.2.2.3. By End-User
6.3.3. Australia Expression Vector Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Host Type
6.3.3.2.2. By Application
6.3.3.2.3. By End-User
6.3.4. Japan Expression Vector Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Host Type
6.3.4.2.2. By Application
6.3.4.2.3. By End-User
6.3.5. South Korea Expression Vector Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Host Type
6.3.5.2.2. By Application
6.3.5.2.3. By End-User
7. Europe Expression Vector Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Host Type
7.2.2. By Application
7.2.3. By End-User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Expression Vector Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Host Type
7.3.1.2.2. By Application
7.3.1.2.3. By End-User
7.3.2. Germany Expression Vector Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Host Type
7.3.2.2.2. By Application
7.3.2.2.3. By End-User
7.3.3. Spain Expression Vector Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Host Type
7.3.3.2.2. By Application
7.3.3.2.3. By End-User
7.3.4. Italy Expression Vector Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Host Type
7.3.4.2.2. By Application
7.3.4.2.3. By End-User
7.3.5. United Kingdom Expression Vector Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Host Type
7.3.5.2.2. By Application
7.3.5.2.3. By End-User
8. North America Expression Vector Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Host Type
8.2.2. By Application
8.2.3. By End-User
8.2.4. By Country
8.3. North America: Country Analysis
8.3.1. United States Expression Vector Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Host Type
8.3.1.2.2. By Application
8.3.1.2.3. By End-User
8.3.2. Mexico Expression Vector Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Host Type
8.3.2.2.2. By Application
8.3.2.2.3. By End-User
8.3.3. Canada Expression Vector Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Host Type
8.3.3.2.2. By Application
8.3.3.2.3. By End-User
9. South America Expression Vector Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Host Type
9.2.2. By Application
9.2.3. By End-User
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Expression Vector Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Host Type
9.3.1.2.2. By Application
9.3.1.2.3. By End-User
9.3.2. Argentina Expression Vector Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Host Type
9.3.2.2.2. By Application
9.3.2.2.3. By End-User
9.3.3. Colombia Expression Vector Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Host Type
9.3.3.2.2. By Application
9.3.3.2.3. By End-User
10. Middle East and Africa Expression Vector Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Host Type
10.2.2. By Application
10.2.3. By End-User
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Expression Vector Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Host Type
10.3.1.2.2. By Application
10.3.1.2.3. By End-User
10.3.2. Saudi Arabia Expression Vector Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Host Type
10.3.2.2.2. By Application
10.3.2.2.3. By End-User
10.3.3. UAE Expression Vector Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Host Type
10.3.3.2.2. By Application
10.3.3.2.3. By End-User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global Expression Vector Market: SWOT Analysis
